Matthew Vincent Dolan - Mar 8, 2024 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Strategy and Corporate
Signature
By: /s/ Jereme M Sylvain For: Matthew Vincent Dolan
Stock symbol
DXCM
Transactions as of
Mar 8, 2024
Transactions value $
$0
Form type
4
Date filed
3/11/2024, 06:30 PM
Previous filing
Sep 1, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +21.7K +64.68% $0.00 55.3K Mar 8, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2 Included in this number are 40,075 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 3,852 of which were granted on March 8, 2022 and shall vest through March 8, 2025.